Press Release
Hamamatsu and AIxMed: The collaboration will allow interoperability between ScanPilot™ and NanoZoomer® scanners for technical image-quality assessment and autonomous rescanning in cytology. BRIDGEWATER, N.J., Sept. 3, 2026 /PRNewswire/...
Hamamatsu: New FDA clearances expand Hamamatsu's FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions. HAMAMATSU, Japan, Sept. 2, 2026 /PRNewswire/ -- Hamamatsu Photonics K.K. today...
Lumea and TreatmentGPS today announced the Alpine Path integration into Lumea’s software. LEHI, UT, UNITED STATES, September 1, 2026 /EINPresswire.com/ -- Lumea, a U.S. leader in digital pathology solutions, and TreatmentGPS, a...
Tempus’ multimodal foundation model offers diagnostic-grade precision for cancer detection and unlocks broader applications predicting biomarker status and patient prognosis CHICAGO, August 4, 2026 — Tempus AI, Inc. (NASDAQ: TEM), a...
NEW YORK--(BUSINESS WIRE)--Ataraxis AI, a frontier clinical artificial intelligence (AI) company developing AI-powered tools for oncology, today announced that its laboratory has received accreditation from the College of American...
August 25, 2026 - Stratipath, a leader in AI-based precision diagnostics for breast cancer, and Aiforia, a pioneer in AI-driven diagnostics in pathology, today announced a strategic partnership. This collaboration aims to provide pathologists...
